[1]
Yosipovitch, G. et al. 2019. Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials. Acta Dermato-Venereologica. 99, 9 (Jun. 2019), 820–821. DOI:https://doi.org/10.2340/00015555-3195.